Chinese biopharma firm Gensciences rakes in $124m in Series A, B rounds

Chinese biopharma firm Gensciences rakes in $124m in Series A, B rounds

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter